Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 3 | Thrombosis Journal

Fig. 3

From: Recombinant human soluble thrombomodulin improves mortality in patients with sepsis especially for severe coagulopathy: a retrospective study

Fig. 3

Serial changes in the sequential organ failure assessment (SOFA) score in the severe coagulopathy group and in the mild coagulopathy group

Open circle: Severe coagulopathy group. Filled circle: Mild coagulopathy group.

Data are expressed as means ± standard deviation. Significant difference compared with day 1. There was trend toward lower SOFA scores in severe coagulopathy group than mild coagulopathy group on day 28 (p = 0.08).

Back to article page